Le Lézard
Classified in: Health, Science and technology
Subjects: PDT, PSF

Val Verde Regional Medical Center Provides Notification- Accessing of Data Security Incident


DEL RIO, Texas, May 26, 2022 /PRNewswire/ -- On March 10, 2022, Val Verde Regional Medical Center ("VVRMC") experienced a data security incident that disrupted its system. Upon discovering this incident, VVRMC immediately launched an investigation and engaged a digital forensics firm to help determine what happened and what information may have been accessed. On March 24, 2022, VVRMC determined that personal information and protected health information belonging to certain individuals was acquired without authorization as part of the incident. The types of information potentially accessed varied by individual, but may have included name, address, Social Security number, medical information, and health insurance information. The specific types of medical information and/or health insurance information that may have been accessed include, provider name(s), patient account number(s), and medical record number(s). 

VVRMC  reported this matter to the FBI and will provide whatever cooperation is necessary to hold perpetrators accountable.  Impacted individuals were notified beginning on May 24, 2022.  The notification included information about this incident and measures that can be taken to protect personal information and protected health information, including free identity monitoring and recovery services.  To enroll in these services, affected individuals must call the toll-free number: (855) 503-2916. Further information can be obtained at https://enroll.krollmonitoring.com.

SOURCE Val Verde Regional Medical Center


These press releases may also interest you

at 22:03
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...



News published on and distributed by: